Taysha Gene Therapies (TSHA) Operating Leases (2022 - 2026)
Taysha Gene Therapies (TSHA) recorded Operating Leases of $6.29 million in Q2 2026, down 62.6% from $16.81 million a year earlier and down 64.6% from the prior quarter.
Powered by 
Analysis
Taysha Gene Therapies (TSHA) Operating Leases (2022 - 2026) Analysis & Trends
At the end of FY2025, Taysha Gene Therapies reported Operating Leases of $18.17 million, up 4.7% from FY2024.
- Annual Operating Leases has a three-year compound annual growth rate of -3.8% (FY2022 to FY2025).
- Across earlier years, Operating Leases came in at $17.36 million in FY2024 (-8.4%), $18.95 million in FY2023 (-7.3%) and $20.44 million in FY2022.
- The Q2 2026 figure is the lowest quarterly Operating Leases in data going back to Q4 2022.
- On a year-over-year basis, Operating Leases rose in two of the last eight quarters, with an average decline of 11.4%.
- Peak year-over-year performance for Operating Leases in the last five years was growth of 4.7% in Q4 2025, against a decline of 62.6% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $17.77 million (Q1 2026), $18.17 million (Q4 2025) and $16.51 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Taysha Gene Therapies | 1.52 Bn | 173.19 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.29 Mn |
| Mar 31, 2026 | 17.77 Mn |
| Dec 31, 2025 | 18.17 Mn |
| Sep 30, 2025 | 16.51 Mn |
| Jun 30, 2025 | 16.81 Mn |
| Mar 31, 2025 | 17.09 Mn |
| Dec 31, 2024 | 17.36 Mn |
| Sep 30, 2024 | 17.75 Mn |
| Jun 30, 2024 | 18.13 Mn |
| Mar 31, 2024 | 18.50 Mn |
| Dec 31, 2023 | 18.95 Mn |
| Sep 30, 2023 | 19.10 Mn |
| Jun 30, 2023 | 19.53 Mn |
| Mar 31, 2023 | 19.93 Mn |
| Dec 31, 2022 | 20.44 Mn |
API Access
Taysha Gene Therapies Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=TSHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "TSHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=TSHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();